Taking multiple medications for chronic disease
Related entities
Findings (27)
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%
None
improvementAmong opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.
Effect: improvement; 71%